Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

BP shares spark on takeover speculation

(Sharecast News) - Shares in BP sparked on Friday, after it was reported that a range of possible suitors were running a slide rule over the oil and gas major. According to the Financial Times, Shell, Chevron, ExxonMobil, TotalEnergies and Abu Dhabi's Adnoc have run the numbers on a potential acquisition. Oil trader Vitol, meanwhile, is also thought to be potentially interested in parts of the business.

BP's share price has fallen sharply over the last year, by 27%. The blue chip announced plans under previous chief executive Bernard Looney to transition away from oil and gas towards renewables, but failed to win over investors.

Under current head Murray Auchincloss, BP has now abandoned the strategy but investors remain unconvinced.

The share price weakness means BP's market capitalisation now stands at around £57bn, well short of the estimated £120bn value of its assets, excluding debt and liabilities.

Activist investor Elliott Management has built a significant stake in BP. An unnamed person close to the firm told the FT: "The continued underperformance of BP makes it open to a takeover."

Any takeover of BP would be complex and including a number of competition and political hurdles. BP also has significant debt of around $77bn and long-term liabilities.

However, it has a wealth of highly-prized assets, including substantial interests in US shale and in the Gulf of Mexico, making it a key target despite the complexity of any deal.

As at 1000 BST, shares in BP were trading 3% higher at 365.63p.

Neil Wilson, UK investor strategist at Saxo Markets, said: "A trend to consolidate more seems inevitable, and BP has opened itself up to be prey by making strategic errors and execution mistakes.

"It's also the case that the US-UK valuation gap means a reverse into a big US major could make sense - BP does a lot of its business there. I'm not sure the government would like a US takeover - easing into Shell would be simpler from a that point of view, but it would be hard for Keir Starmer to tell Donald Trump that he's blocking [a US firm] from doing business."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.